Apixaban
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06605 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with or without aura, susceptibility to | KG + DL |
| 3 | leprosy | KG + DL |
| 4 | rheumatoid arthritis | KG + DL |
| 5 | migraine with brainstem aura | KG + DL |
| 6 | Prinzmetal angina | KG + DL |
| 7 | brachydactyly-syndactyly syndrome | KG + DL |
| 8 | pulmonary hypertension | KG + DL |
| 9 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 10 | kyphoscoliotic heart disease | KG + DL |
| 11 | atrophoderma vermiculata | KG + DL |
| 12 | ulerythema ophryogenesis | KG + DL |
| 13 | thrombotic disease | KG + DL |
| 14 | hemoglobinopathy | KG + DL |
| 15 | female breast carcinoma | KG + DL |
| 16 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 17 | gout | KG + DL |
| 18 | lymphocytic hypereosinophilic syndrome | KG + DL |
| 19 | collagenopathy | KG + DL |
| 20 | conjunctivitis | KG + DL |
| 21 | vein disease | KG + DL |
| 22 | homozygous familial hypercholesterolemia | KG + DL |
| 23 | oral candidiasis | KG + DL |
| 24 | arteriosclerosis disorder | KG + DL |
| 25 | heart disease | KG + DL |
| 26 | Laubry-Pezzi syndrome | KG + DL |
| 27 | heart conduction disease | KG + DL |
| 28 | angiodysplasia | KG + DL |
| 29 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 30 | hyperthyroidism | KG + DL |
| 31 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 32 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 33 | venous thromboembolism | KG + DL |
| 34 | fibrocartilaginous embolism | KG + DL |
| 35 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 36 | Jeune syndrome situs inversus | KG + DL |
| 37 | generalized atherosclerosis | KG + DL |
| 38 | cerebral atherosclerosis | KG + DL |
| 39 | orofacial clefting syndrome | KG + DL |
| 40 | tendinitis | KG + DL |
| 41 | interventricular septum aneurysm | KG + DL |
| 42 | pulmonary valve disease | KG + DL |
| 43 | beta-thalassemia with other manifestations | KG + DL |
| 44 | disorder of fucoglycosan synthesis | KG + DL |
| 45 | non-inflammatory vasculopathy | KG + DL |
| 46 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 47 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 48 | idiopathic granulomatous myositis | KG + DL |
| 49 | myositis fibrosa | KG + DL |
| 50 | commissural lip fistula | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.